A diabeteses cardialis autonóm neuropathia diagnosztikája

Translated title of the contribution: Diagnosis of diabetic cardiac autonomic neuropathy

Sztanek Ferenc, Jebelovszki Éva, Gaszner Balázs, Zrínyi Miklós, Páll Dénes, P. Kempler, Harangi Mariann

Research output: Contribution to journalArticle

Abstract

Cardiac autonomic neuropathy (CAN) is a common complication in type 1 and 2 diabetes and is defined as the impairment of autonomic control of the cardiovascular system. CAN is strongly associated with increased mortality, and in some studies with morbidity of vascular complications, such as stroke, coronary artery disease and myocardial infarction. At the early stages, CAN can be subclinical and it becomes clinically evident as the disease progresses. Sub-clinically, the disease is defined by cardiovascular reflex testing, which may have prognostic implications. Clinically, the impairment in autonomic function is associated with resting tachycardia, exercise intolerance, orthostatic hypo-tension, syncope, intraoperative cardiovascular instability, silent myocardial infarction and ischemia, and increased mortality. Although very common and serious, CAN is a frequently overlooked complication of diabetes. Because the progression of cardiovascular denervation is partly reversible or can be slowed down in the early stages of the disease, recent guidelines strongly recommend screening for CAN in patients with diabetes. In this review we summarize the diagnostic tools suggested in the screening for diabetic CAN.

Original languageHungarian
Pages (from-to)1366-1375
Number of pages10
JournalOrvosi hetilap
Volume160
Issue number35
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Diabetic Neuropathies
Diabetes Mellitus
Orthostatic Intolerance
Myocardial Infarction
Mortality
Syncope
Denervation
Diabetes Complications
Cardiovascular System
Type 1 Diabetes Mellitus
Tachycardia
Type 2 Diabetes Mellitus
Myocardial Ischemia
Blood Vessels
Reflex
Coronary Artery Disease
Stroke
Guidelines
Exercise
Morbidity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ferenc, S., Éva, J., Balázs, G., Miklós, Z., Dénes, P., Kempler, P., & Mariann, H. (2019). A diabeteses cardialis autonóm neuropathia diagnosztikája. Orvosi hetilap, 160(35), 1366-1375. https://doi.org/10.1556/650.2019.31491

A diabeteses cardialis autonóm neuropathia diagnosztikája. / Ferenc, Sztanek; Éva, Jebelovszki; Balázs, Gaszner; Miklós, Zrínyi; Dénes, Páll; Kempler, P.; Mariann, Harangi.

In: Orvosi hetilap, Vol. 160, No. 35, 01.01.2019, p. 1366-1375.

Research output: Contribution to journalArticle

Ferenc, S, Éva, J, Balázs, G, Miklós, Z, Dénes, P, Kempler, P & Mariann, H 2019, 'A diabeteses cardialis autonóm neuropathia diagnosztikája', Orvosi hetilap, vol. 160, no. 35, pp. 1366-1375. https://doi.org/10.1556/650.2019.31491
Ferenc S, Éva J, Balázs G, Miklós Z, Dénes P, Kempler P et al. A diabeteses cardialis autonóm neuropathia diagnosztikája. Orvosi hetilap. 2019 Jan 1;160(35):1366-1375. https://doi.org/10.1556/650.2019.31491
Ferenc, Sztanek ; Éva, Jebelovszki ; Balázs, Gaszner ; Miklós, Zrínyi ; Dénes, Páll ; Kempler, P. ; Mariann, Harangi. / A diabeteses cardialis autonóm neuropathia diagnosztikája. In: Orvosi hetilap. 2019 ; Vol. 160, No. 35. pp. 1366-1375.
@article{f944be158077493495c57c6026747bcf,
title = "A diabeteses cardialis auton{\'o}m neuropathia diagnosztik{\'a}ja",
abstract = "Cardiac autonomic neuropathy (CAN) is a common complication in type 1 and 2 diabetes and is defined as the impairment of autonomic control of the cardiovascular system. CAN is strongly associated with increased mortality, and in some studies with morbidity of vascular complications, such as stroke, coronary artery disease and myocardial infarction. At the early stages, CAN can be subclinical and it becomes clinically evident as the disease progresses. Sub-clinically, the disease is defined by cardiovascular reflex testing, which may have prognostic implications. Clinically, the impairment in autonomic function is associated with resting tachycardia, exercise intolerance, orthostatic hypo-tension, syncope, intraoperative cardiovascular instability, silent myocardial infarction and ischemia, and increased mortality. Although very common and serious, CAN is a frequently overlooked complication of diabetes. Because the progression of cardiovascular denervation is partly reversible or can be slowed down in the early stages of the disease, recent guidelines strongly recommend screening for CAN in patients with diabetes. In this review we summarize the diagnostic tools suggested in the screening for diabetic CAN.",
keywords = "Cardiac autonomic neuropathy, Cardiovascular reflex test, Diabetes mellitus, Heart-rate variability, Questionnaire",
author = "Sztanek Ferenc and Jebelovszki {\'E}va and Gaszner Bal{\'a}zs and Zr{\'i}nyi Mikl{\'o}s and P{\'a}ll D{\'e}nes and P. Kempler and Harangi Mariann",
year = "2019",
month = "1",
day = "1",
doi = "10.1556/650.2019.31491",
language = "Hungarian",
volume = "160",
pages = "1366--1375",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "35",

}

TY - JOUR

T1 - A diabeteses cardialis autonóm neuropathia diagnosztikája

AU - Ferenc, Sztanek

AU - Éva, Jebelovszki

AU - Balázs, Gaszner

AU - Miklós, Zrínyi

AU - Dénes, Páll

AU - Kempler, P.

AU - Mariann, Harangi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Cardiac autonomic neuropathy (CAN) is a common complication in type 1 and 2 diabetes and is defined as the impairment of autonomic control of the cardiovascular system. CAN is strongly associated with increased mortality, and in some studies with morbidity of vascular complications, such as stroke, coronary artery disease and myocardial infarction. At the early stages, CAN can be subclinical and it becomes clinically evident as the disease progresses. Sub-clinically, the disease is defined by cardiovascular reflex testing, which may have prognostic implications. Clinically, the impairment in autonomic function is associated with resting tachycardia, exercise intolerance, orthostatic hypo-tension, syncope, intraoperative cardiovascular instability, silent myocardial infarction and ischemia, and increased mortality. Although very common and serious, CAN is a frequently overlooked complication of diabetes. Because the progression of cardiovascular denervation is partly reversible or can be slowed down in the early stages of the disease, recent guidelines strongly recommend screening for CAN in patients with diabetes. In this review we summarize the diagnostic tools suggested in the screening for diabetic CAN.

AB - Cardiac autonomic neuropathy (CAN) is a common complication in type 1 and 2 diabetes and is defined as the impairment of autonomic control of the cardiovascular system. CAN is strongly associated with increased mortality, and in some studies with morbidity of vascular complications, such as stroke, coronary artery disease and myocardial infarction. At the early stages, CAN can be subclinical and it becomes clinically evident as the disease progresses. Sub-clinically, the disease is defined by cardiovascular reflex testing, which may have prognostic implications. Clinically, the impairment in autonomic function is associated with resting tachycardia, exercise intolerance, orthostatic hypo-tension, syncope, intraoperative cardiovascular instability, silent myocardial infarction and ischemia, and increased mortality. Although very common and serious, CAN is a frequently overlooked complication of diabetes. Because the progression of cardiovascular denervation is partly reversible or can be slowed down in the early stages of the disease, recent guidelines strongly recommend screening for CAN in patients with diabetes. In this review we summarize the diagnostic tools suggested in the screening for diabetic CAN.

KW - Cardiac autonomic neuropathy

KW - Cardiovascular reflex test

KW - Diabetes mellitus

KW - Heart-rate variability

KW - Questionnaire

UR - http://www.scopus.com/inward/record.url?scp=85071459745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071459745&partnerID=8YFLogxK

U2 - 10.1556/650.2019.31491

DO - 10.1556/650.2019.31491

M3 - Article

VL - 160

SP - 1366

EP - 1375

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 35

ER -